The PD-L1-induced changes in intracellular signaling beyond immunity may define new mechanisms through which the PD1/PD-L1 axis facilitates tumor cell progression and development and indicate new therapeutic strategies for patients with lung cancer. This evidence concerns the gene PDCD1 and lung cancer.